Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
1 drug for “CD55-deficient Protein-losing Enteropathy”
Approved 1
- PozelimabREGENERON PHARMACEUTICALS, INC.CD55-deficient Protein-losing Enteropathy
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.